ArticleClinicoEconomics and outcomes research : CEOR2019
North American cost analysis of brand name versus generic drugs for the treatment of glaucoma.
Monali S Malvankar-Mehta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it